Harbor Asset Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.8K Hold
313
0.06% 169
2026
Q1
$68.1K Hold
313
0.06% 175
2025
Q4
$71.5K Hold
313
0.06% 160
2025
Q3
$72.5K Hold
313
0.06% 158
2025
Q2
$58.1K Buy
+313
New +$58.2K 0.06% 167

Other funds holding ABBV

Harbor Asset Planning's ABBV Position: Q2 2026 in Review

Harbor Asset Planning held its AbbVie (ABBV) position steady in Q2 2026 at 313 shares worth $78.8K. The position accounts for 0.06% of the portfolio, ranked #169.

Harbor Asset Planning first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harbor Asset Planning held 313 shares of AbbVie worth $78.8K as of Q2 2026.
  • Harbor Asset Planning left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.06% of Harbor Asset Planning's portfolio in Q2 2026, its #169 holding.
  • Harbor Asset Planning first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harbor Asset Planning's 13F filing for Q2 2026, filed 22 Jul 2026.